Posts Tagged ‘its-board

Activist investor Carl Icahn has abandoned his proxy fight at Genzyme Corp in return for the biotechnology company’s acceptance of two of his representatives to its board.

Activist investor Carl Icahn has abandoned his proxy fight at Genzyme Corp in return for the biotechnology company’s acceptance of two of his representatives to its board.

StemCells Inc.

Fibrocell Science Inc., an Exton biotechnology company focused on the development of regenerative cell therapy, has appointed Marc B.

MADISON, Wis.—-BioForward, the member-driven organization that represents the state’s biotechnology industry, today announced the 2010 executive committee members of its board of directors.


About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.

Biotech

    Amrita university onam 2010Amrita university onam 2010amrita biotechnology saraswatiamrita biotechnology saraswatiamrita biotechnology saraswati amrita biotechnology onam 2010